TG Therapeutics, Inc. (TGTX)
Nasdaq: TGTX · Pharmaceutical Preparations · New York, NY · filing with the SEC since 1996
Grade7.3
◀ Past 6.5● Present 8.6▶ Future 6.2
Who runs TG Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Weiss Michael S
CEO. First filing Jan 2012, latest Jan 9, 2026, 3 filings in all.
Officers reporting now
2
of 7 people with a filing in the last fifteen months
Directors reporting now
5
9 people on the record since 2012
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Weiss Michael S | CEO | Jan 2012 | Jan 9, 2026 | none |
| Power Sean A | CFO | Jan 2012 | Jan 9, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Charney Laurence N | director | Apr 2012 | Sep 14, 2026 | 1 · $300,000 |
| Echelard Yann | director | Dec 2012 | Jun 15, 2026 | 1 · $200,000 |
| Hoberman Kenneth | director | Dec 2014 | Jun 15, 2026 | none |
| Hume Daniel | director | Jun 2015 | Jun 15, 2026 | none |
| Lonial Sagar | director | Jun 2020 | Jun 15, 2026 | none |
Earlier names on the record6, newest filing first
Kolchinsky Peter · 10% owner · last filing Sep 2020Ra Capital Management, L.P. · 10% owner · last filing Sep 2020Shah Rajeev M. · 10% owner · last filing Sep 2020Kennedy William James · director · last filing Jun 2020Ra Capital Healthcare Fund LP · 10% owner · last filing May 2020Schoenebaum Mark · director · last filing Jun 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.